Arca
Skip to content
Tools
Tools

Cystine

Small molecule in Homo sapiens that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Cysteamine

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        CysteamineApprovedLeadiant BiosciencesSmall moleculeReducing agentCystine reducing agent7

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 7 in all, from ClinicalTrials.gov.
        Pilot Study of TTI-0102 in CystinosisCysteaminePhase 2Not yet recruitingThiogenesis Therapeutics, Inc.Sep 23, 2026
        European Cystinosis Cohort 2Cysteamine—Not yet recruitingInstitut National de la Santé Et de la Recherche Médicale, FranceJul 2, 2026
        Cystinosis and Mitochondrial MetabolismCysteamineNot applicableRecruitingHospices Civils de LyonJan 6, 2026
        A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)CysteaminePhase 2Not yet recruitingThiogenesis Therapeutics, Inc.May 25, 2025
        DFT383 in Pediatric Participants With Nephropathic CystinosisCysteaminePhase 1 / Phase 2RecruitingNovartis PharmaceuticalsApr 4, 2025
        Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaCysteaminePhase 3RecruitingUMC UtrechtApr 13, 2016
        Use of Cysteamine in the Treatment of CystinosisCysteamine—RecruitingNational Human Genome Research Institute (NHGRI)Aug 2, 2006

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364039, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.